Micro Medical Solutions: First Case Completed in STAND Study, the Pivotal Clinical Trial of MicroStent
Major milestone reached in journey toward FDA approval for potentially limb-saving treatment of peripheral artery disease WILMINGTON, Mass., May 12 , 2020 — Micro Medical Solutions (MMS) today announced the first implantation of the MicroStent vascular stent in the FDA randomized, multicenter pivotal clinical study, STAND (A Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt […]
Clinical investigators will study the safety and efficacy of this microvascular device designed to restore blood flow and reduce amputations resulting from below the knee peripheral artery disease WILMINGTON, Mass., June 24, 2019 — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced […]
The company establishes networks to deliver this critical technology following recent approvals in the EU and Latin America. WILMINGTON, Mass., March 12, 2019 — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced today that it has established distribution agreements for MicroStent in […]
As MMS prepares for approval of their pivotal clinical trial of the company’s flagship MicroStent device, one of healthcare’s top growth experts will help shape the company’s future WILMINGTON, Mass., May 14, 2019 — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions that improve clinical outcomes and quality of life, announced […]
With a longer, more robust access system and new stent sizes, physicians have more options to access and open arteries affected by critical limb ischemia and prevent lower-leg amputations. WILMINGTON, Massachusetts, November 5, 2018 — Micro Medical Solutions (MMS), an innovator in the field of microvascular interventions designed to improve clinical outcomes and quality of […]
A clinical trial is underway for the MicroStent microvascular device, which is designed to open occluded arteries and prevent below-the-knee amputations.
Micro Medical Solutions Announces International Scientific Advisory Board to Guide and Advance Clinical Development
To accelerate study of the MicroStent microvascular device and other new technologies designed to prevent amputation, MMS has assembled six world leaders in treating peripheral artery disease and critical limb ischemia.
Wilmington, MA April 11, 2018—Micro Medical Solutions (MMS) is positioning itself for growth and product commercialization with the recent addition of two new employees to its organization: Amanda Panos as Vice President, Clinical Affairs, and Sarrah Val as Director of Clinical Affairs. Ms. Panos brings 20 years of experience in the medical device industry, where […]
Promotions Announced at Micro Medical Solutions; Organizational Changes Affect Regulatory Affairs, R&D, Quality Assurance
Micro Medical Solutions is pleased to announce an organizational change that includes the promotions of three key members of the company’s executive team.